These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 34879325)
1. Phospholipid nanoparticles: Therapeutic potentials against atherosclerosis via reducing cholesterol crystals and inhibiting inflammation. Luo Y; Guo Y; Wang H; Yu M; Hong K; Li D; Li R; Wen B; Hu D; Chang L; Zhang J; Yang B; Sun D; Schwendeman AS; Eugene Chen Y EBioMedicine; 2021 Dec; 74():103725. PubMed ID: 34879325 [TBL] [Abstract][Full Text] [Related]
2. Qing-Xue-Xiao-Zhi formula attenuates atherosclerosis by inhibiting macrophage lipid accumulation and inflammatory response via TLR4/MyD88/NF-κB pathway regulation. Li Y; Zhang L; Ren P; Yang Y; Li S; Qin X; Zhang M; Zhou M; Liu W Phytomedicine; 2021 Dec; 93():153812. PubMed ID: 34753029 [TBL] [Abstract][Full Text] [Related]
3. In Vivo PET Imaging of HDL in Multiple Atherosclerosis Models. Pérez-Medina C; Binderup T; Lobatto ME; Tang J; Calcagno C; Giesen L; Wessel CH; Witjes J; Ishino S; Baxter S; Zhao Y; Ramachandran S; Eldib M; Sánchez-Gaytán BL; Robson PM; Bini J; Granada JF; Fish KM; Stroes ES; Duivenvoorden R; Tsimikas S; Lewis JS; Reiner T; Fuster V; Kjær A; Fisher EA; Fayad ZA; Mulder WJ JACC Cardiovasc Imaging; 2016 Aug; 9(8):950-61. PubMed ID: 27236528 [TBL] [Abstract][Full Text] [Related]
4. Bifunctional supramolecular nanofiber inhibits atherosclerosis by enhancing plaque stability and anti-inflammation in apoE Shang Y; Ma C; Zhang J; Wang Z; Ren C; Luo X; Peng R; Liu J; Mao J; Shi Y; Fan G Theranostics; 2020; 10(22):10231-10244. PubMed ID: 32929345 [No Abstract] [Full Text] [Related]
5. Apolipoprotein E-/- Mice Lacking Hemopexin Develop Increased Atherosclerosis via Mechanisms That Include Oxidative Stress and Altered Macrophage Function. Mehta NU; Grijalva V; Hama S; Wagner A; Navab M; Fogelman AM; Reddy ST Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1152-63. PubMed ID: 27079878 [TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein AI) Promotes Atherosclerosis Regression in Diabetic Mice by Suppressing Myelopoiesis and Plaque Inflammation. Barrett TJ; Distel E; Murphy AJ; Hu J; Garshick MS; Ogando Y; Liu J; Vaisar T; Heinecke JW; Berger JS; Goldberg IJ; Fisher EA Circulation; 2019 Oct; 140(14):1170-1184. PubMed ID: 31567014 [TBL] [Abstract][Full Text] [Related]
8. Targeted Therapy of Atherosclerosis by a Broad-Spectrum Reactive Oxygen Species Scavenging Nanoparticle with Intrinsic Anti-inflammatory Activity. Wang Y; Li L; Zhao W; Dou Y; An H; Tao H; Xu X; Jia Y; Lu S; Zhang J; Hu H ACS Nano; 2018 Sep; 12(9):8943-8960. PubMed ID: 30114351 [TBL] [Abstract][Full Text] [Related]
9. Anchoring β-CD on simvastatin-loaded rHDL for selective cholesterol crystals dissolution and enhanced anti-inflammatory effects in macrophage/foam cells. He J; Zhou X; Xu F; He H; Ma S; Liu X; Zhang M; Zhang W; Liu J Eur J Pharm Biopharm; 2022 May; 174():144-154. PubMed ID: 35447349 [TBL] [Abstract][Full Text] [Related]
10. Hexarelin attenuates atherosclerosis via inhibiting LOX-1-NF-κB signaling pathway-mediated macrophage ox-LDL uptake in ApoE Cheng XL; Ding F; Wang DP; Zhou L; Cao JM Peptides; 2019 Nov; 121():170122. PubMed ID: 31386895 [TBL] [Abstract][Full Text] [Related]
14. A novel small molecule liver X receptor transcriptional regulator, nagilactone B, suppresses atherosclerosis in apoE-deficient mice. Gui Y; Yao S; Yan H; Hu L; Yu C; Gao F; Xi C; Li H; Ye Y; Wang Y Cardiovasc Res; 2016 Oct; 112(1):502-14. PubMed ID: 27460841 [TBL] [Abstract][Full Text] [Related]
15. Tanshinone IIA Promotes Macrophage Cholesterol Efflux and Attenuates Atherosclerosis of apoE-/- Mice by Omentin-1/ABCA1 Pathway. Tan YL; Ou HX; Zhang M; Gong D; Zhao ZW; Chen LY; Xia XD; Mo ZC; Tang CK Curr Pharm Biotechnol; 2019; 20(5):422-432. PubMed ID: 30947667 [TBL] [Abstract][Full Text] [Related]
16. Anti-Inflammatory Effects of HDL (High-Density Lipoprotein) in Macrophages Predominate Over Proinflammatory Effects in Atherosclerotic Plaques. Fotakis P; Kothari V; Thomas DG; Westerterp M; Molusky MM; Altin E; Abramowicz S; Wang N; He Y; Heinecke JW; Bornfeldt KE; Tall AR Arterioscler Thromb Vasc Biol; 2019 Dec; 39(12):e253-e272. PubMed ID: 31578081 [TBL] [Abstract][Full Text] [Related]
17. Adipocyte enhancer-binding protein 1 (AEBP1) (a novel macrophage proinflammatory mediator) overexpression promotes and ablation attenuates atherosclerosis in ApoE (-/-) and LDLR (-/-) mice. Bogachev O; Majdalawieh A; Pan X; Zhang L; Ro HS Mol Med; 2011; 17(9-10):1056-64. PubMed ID: 21687917 [TBL] [Abstract][Full Text] [Related]
18. PSRC1 overexpression attenuates atherosclerosis progression in apoE Guo K; Hu L; Xi D; Zhao J; Liu J; Luo T; Ma Y; Lai W; Guo Z J Mol Cell Cardiol; 2018 Mar; 116():69-80. PubMed ID: 29378206 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-19b promotes macrophage cholesterol accumulation and aortic atherosclerosis by targeting ATP-binding cassette transporter A1. Lv YC; Tang YY; Peng J; Zhao GJ; Yang J; Yao F; Ouyang XP; He PP; Xie W; Tan YL; Zhang M; Liu D; Tang DP; Cayabyab FS; Zheng XL; Zhang DW; Tian GP; Tang CK Atherosclerosis; 2014 Sep; 236(1):215-26. PubMed ID: 25084135 [TBL] [Abstract][Full Text] [Related]
20. CER-001, a HDL-mimetic, stimulates the reverse lipid transport and atherosclerosis regression in high cholesterol diet-fed LDL-receptor deficient mice. Tardy C; Goffinet M; Boubekeur N; Ackermann R; Sy G; Bluteau A; Cholez G; Keyserling C; Lalwani N; Paolini JF; Dasseux JL; Barbaras R; Baron R Atherosclerosis; 2014 Jan; 232(1):110-8. PubMed ID: 24401224 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]